Woodline Partners’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RG
BI
PA
RCMNY
CS
FCM
Woodline Partners's ZYME Position: Q1 2023 in Review
Woodline Partners sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 600,403 shares — an estimated $4.72M sold.
Woodline Partners first reported a position in ZYME in Q4 2019 and held it in 9 quarters. The position peaked at $34.1M in Q2 2020. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.
- Woodline Partners reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
- Woodline Partners sold 600,403 Zymeworks shares in Q1 2023, an estimated $4.72M.
- Woodline Partners first reported a position in Zymeworks in Q4 2019 and held it in 9 quarters.
- Woodline Partners's Zymeworks position peaked at $34.1M in Q2 2020.
- 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.
Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.